Synergic pro-apoptotic effects of Ferulic Acid and nanostructured lipid carrier in glioblastoma cells assessed through molecular and Delayed Luminescence studies

[1]  P. Pawar,et al.  Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier , 2019, Journal of Drug Delivery Science and Technology.

[2]  S. Samuel,et al.  Flavonoids in Cancer and Apoptosis , 2018, Cancers.

[3]  Saeedeh Jafari Nodooshan,et al.  Preparation and investigation of indirubin‐loaded SLN nanoparticles and their anti‐cancer effects on human glioblastoma U87MG cells , 2018, Cell biology international.

[4]  C. Chinopoulos,et al.  Mitochondrial Substrate-Level Phosphorylation as Energy Source for Glioblastoma: Review and Hypothesis , 2018, ASN neuro.

[5]  Keisuke Hikosaka,et al.  NAD Metabolism in Cancer Therapeutics , 2018, Front. Oncol..

[6]  A. Haeri,et al.  Preparation, In-Vitro Characterization and Pharmacokinetic Evaluation of Brij Decorated Doxorubicin Liposomes as a Potential Nanocarrier for Cancer Therapy , 2018, Iranian journal of pharmaceutical research : IJPR.

[7]  C. V. von Arnim,et al.  NADH Autofluorescence—A Marker on its Way to Boost Bioenergetic Research , 2018, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[8]  Hui-ying Yu,et al.  The anticancer effects of ferulic acid is associated with induction of cell cycle arrest and autophagy in cervical cancer cells , 2018, Cancer Cell International.

[9]  P. Porporato,et al.  Signaling Pathways Regulating Redox Balance in Cancer Metabolism , 2018, Front. Oncol..

[10]  T. Aminabhavi,et al.  Nanomedicine: An effective tool in cancer therapy. , 2018, International journal of pharmaceutics.

[11]  K. Hirasawa,et al.  Enhancement of Cancer-Specific Protoporphyrin IX Fluorescence by Targeting Oncogenic Ras/MEK Pathway , 2018, Theranostics.

[12]  Roger M. Leblanc,et al.  Crossing the blood‐brain barrier with nanoparticles , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Silvia Anahi Valdés-Rives,et al.  Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications , 2017, BioMed research international.

[14]  T. Hortobágyi,et al.  PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma , 2017, Oncotarget.

[15]  M. Foti,et al.  Quercetin derivatives as potent inducers of selective cytotoxicity in glioma cells , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[16]  V. Naidu,et al.  Mitochondrial Dysfunction in Gliomas: Pharmacotherapeutic Potential of Natural Compounds , 2016, Current neuropharmacology.

[17]  Francesco Musumeci,et al.  The delayed luminescence spectroscopy as tool to investigate the cytotoxic effect on human cancer cells of drug-loaded nanostructured lipid carrier , 2016, SPIE Photonics Europe.

[18]  C. Carbone,et al.  Innovative hybrid vs polymeric nanocapsules: The influence of the cationic lipid coating on the "4S". , 2016, Colloids and surfaces. B, Biointerfaces.

[19]  B. Pineda,et al.  Role of Redox Status in Development of Glioblastoma , 2016, Front. Immunol..

[20]  X. Gong,et al.  Ferulic acid inhibits proliferation and promotes apoptosis via blockage of PI3K/Akt pathway in osteosarcoma cell. , 2016, American journal of translational research.

[21]  M. M. Rizvi,et al.  Redox cycling of endogenous copper by ferulic acid leads to cellular DNA breakage and consequent cell death: A putative cancer chemotherapy mechanism. , 2015, Toxicology and Applied Pharmacology.

[22]  H. Um.  Bcl-2 family proteins as regulators of cancer cell invasion and metastasis: a review focusing on mitochondrial respiration and reactive oxygen species , 2015, Oncotarget.

[23]  M. H. Santana,et al.  Sodium alginate-cross-linked polymyxin B sulphate-loaded solid lipid nanoparticles: Antibiotic resistance tests and HaCat and NIH/3T3 cell viability studies. , 2015, Colloids and surfaces. B, Biointerfaces.

[24]  S. Dhar,et al.  Targeted nanoparticles in mitochondrial medicine. , 2015, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[25]  Francesco Musumeci,et al.  Delayed luminescence to monitor programmed cell death induced by berberine on thyroid cancer cells , 2014, Journal of biomedical optics.

[26]  Irina Baran,et al.  Ultra-weak delayed luminescence in cancer research: a review of the results by the ARETUSA equipment. , 2014, Journal of photochemistry and photobiology. B, Biology.

[27]  Naresh Kumar,et al.  Potential applications of ferulic acid from natural sources , 2014, Biotechnology reports.

[28]  Giovanni Puglisi,et al.  The critical role of didodecyldimethylammonium bromide on physico-chemical, technological and biological properties of NLC. , 2014, Colloids and surfaces. B, Biointerfaces.

[29]  Giuseppina Raciti,et al.  FA-loaded lipid drug delivery systems: preparation, characterization and biological studies. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[30]  Irina Baran,et al.  Mitochondrial respiratory complex I probed by delayed luminescence spectroscopy , 2013, Journal of biomedical optics.

[31]  T. Mak,et al.  Modulation of oxidative stress as an anticancer strategy , 2013, Nature Reviews Drug Discovery.

[32]  Arnab Mukherjee,et al.  Characterization of Flavin-Based Fluorescent Proteins: An Emerging Class of Fluorescent Reporters , 2013, PloS one.

[33]  J. Neuzil,et al.  Classification of mitocans, anti-cancer drugs acting on mitochondria. , 2013, Mitochondrion.

[34]  H. Grossart,et al.  Toxicant Induced Changes on Delayed Fluorescence Decay Kinetics of Cyanobacteria and Green Algae: A Rapid and Sensitive Biotest , 2013, PloS one.

[35]  Filippo Piffaretti,et al.  Real-time, in vivo measurement of tissular pO2 through the delayed fluorescence of endogenous protoporphyrin IX during photodynamic therapy , 2012, Journal of biomedical optics.

[36]  C. Sinico,et al.  Idebenone-loaded solid lipid nanoparticles for drug delivery to the skin: in vitro evaluation. , 2012, International journal of pharmaceutics.

[37]  A. Letai,et al.  BCL2 suppresses PARP1 function and nonapoptotic cell death. , 2012, Cancer research.

[38]  J. Cen,et al.  Rap1GAP alters leukemia cell differentiation, apoptosis and invasion in vitro. , 2012, Oncology reports.

[39]  Irina Baran,et al.  Detailed Analysis of Apoptosis and Delayed Luminescence of Human Leukemia Jurkat T Cells after Proton Irradiation and Treatments with Oxidant Agents and Flavonoids , 2012, Oxidative medicine and cellular longevity.

[40]  Lei Zhang,et al.  Spectral discrimination between normal and leukemic human sera using delayed luminescence , 2012, Biomedical optics express.

[41]  Yun-jie Wang,et al.  Expression and correlation of Bcl-2 with pathological grades in human glioma stem cells. , 2012, Oncology reports.

[42]  Giuseppina Raciti,et al.  Expression of tissue transglutaminase on primary olfactory ensheathing cells cultures exposed to stress conditions , 2012, Neuroscience Research.

[43]  T. Wakabayashi,et al.  Current Trends in Targeted Therapies for Glioblastoma Multiforme , 2012, Neurology research international.

[44]  P. Bosco,et al.  PARP-1 protein expression in glioblastoma multiforme , 2012, European journal of histochemistry : EJH.

[45]  A. Menssen,et al.  The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop , 2011, Proceedings of the National Academy of Sciences.

[46]  Corinne E Griguer,et al.  Bioenergetics pathways and therapeutic resistance in gliomas: emerging role of mitochondria. , 2011, Current pharmaceutical design.

[47]  Irina Baran,et al.  Effects of Menadione, Hydrogen Peroxide, and Quercetin on Apoptosis and Delayed Luminescence of Human Leukemia Jurkat T-Cells , 2010, Cell Biochemistry and Biophysics.

[48]  A. Baschnagel,et al.  Long‐term quality of life after radiotherapy for the treatment of anal cancer , 2010, Cancer.

[49]  S. Shen,et al.  Contribution of reactive oxygen species to migration/invasion of human glioblastoma cells U87 via ERK-dependent COX-2/PGE2 activation , 2010, Neurobiology of Disease.

[50]  N. Banik,et al.  Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes , 2009, Cancer.

[51]  Jae-hoon Park,et al.  The critical role of ERK in death resistance and invasiveness of hypoxia-selected glioblastoma cells , 2009, BMC Cancer.

[52]  W. Y. Seow,et al.  Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug. , 2009, Biomacromolecules.

[53]  Hui Wang,et al.  c-Myc Is Required for Maintenance of Glioma Cancer Stem Cells , 2008, PloS one.

[54]  Can Ince,et al.  In vivo mitochondrial oxygen tension measured by a delayed fluorescence lifetime technique. , 2008, Biophysical journal.

[55]  R. Pellegrino,et al.  Loss of cardiolipin in palmitate‐treated GL15 glioblastoma cells favors cytochrome c release from mitochondria leading to apoptosis , 2008, Journal of neurochemistry.

[56]  Guang Yao,et al.  Sensing and Integration of Erk and PI3K Signals by Myc , 2008, PLoS Comput. Biol..

[57]  M. Cohen-Armon.  PARP-1 activation in the ERK signaling pathway. , 2007, Trends in pharmacological sciences.

[58]  Stefan Trapp,et al.  Mitochondriotropics: a review of their mode of action, and their applications for drug and DNA delivery to mammalian mitochondria. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[59]  Can Ince,et al.  Mitochondrial PO2 measured by delayed fluorescence of endogenous protoporphyrin IX , 2006, Nature Methods.

[60]  Li Zhang,et al.  Prognostic Associations of Activated Mitogen-Activated Protein Kinase and Akt Pathways in Glioblastoma , 2006, Clinical Cancer Research.

[61]  C. Carbone,et al.  Effect of Oil Phase Lipophilicity on In Vitro Drug Release from O/W Microemulsions with Low Surfactant Content , 2006, Drug development and industrial pharmacy.

[62]  Bernard Valeur,et al.  Mathematical functions for the analysis of luminescence decays with underlying distributions: 2. Becquerel (compressed hyperbola) and related decay functions , 2005 .

[63]  Francesco Musumeci,et al.  Discrimination between normal and cancer cells by using spectral analysis of delayed luminescence. , 2005 .

[64]  Andreas Trumpp,et al.  More than just proliferation: Myc function in stem cells. , 2005, Trends in cell biology.

[65]  G. Li Volti,et al.  Glutamate‐evoked redox state alterations are involved in tissue transglutaminase upregulation in primary astrocyte cultures , 2004, FEBS letters.

[66]  R. Mumper,et al.  Paclitaxel nanoparticles for the potential treatment of brain tumors. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[67]  G. Raciti,et al.  Glutamate-induced increases in transglutaminase activity in primary cultures of astroglial cells , 2003, Brain Research.

[68]  R. Müller,et al.  Nanostructured lipid matrices for improved microencapsulation of drugs. , 2002, International journal of pharmaceutics.

[69]  Qiang Zhang,et al.  In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel. , 2001, Chemical & pharmaceutical bulletin.

[70]  F Musumeci,et al.  Delayed luminescence of biological systems arising from correlated many-soliton states. , 2001, Physical review. E, Statistical, nonlinear, and soft matter physics.

[71]  A. Scordino,et al.  Physical aspects of delayed luminescence inAcetabularia acetabulum , 1993, Experientia.

[72]  A. Krasnovsky,et al.  Time-resolved measurements of singlet oxygen dimol-sensitized luminescence , 1993 .

[73]  W. Schmidt,et al.  Long-term delayed luminescence in Scenedesmus obliquus. II. Influence of exogeneous factors , 1987 .

[74]  T. G. Scott,et al.  Synthetic spectroscopic models related to coenzymes and base pairs. V. Emission properties of NADH. Studies of fluorescence lifetimes and quantum efficiencies of NADH, AcPyADH, [reduced acetylpyridineadenine dinucleotide] and simplified synthetic models , 1970 .

[75]  Bernard L. Strehler,et al.  LIGHT PRODUCTION BY GREEN PLANTS , 1951, The Journal of general physiology.

[76]  G. Lenaz.  Mitochondria and reactive oxygen species. Which role in physiology and pathology? , 2012, Advances in experimental medicine and biology.

[77]  L. Lanzanó,et al.  Delayed Luminescence From Collagen as Arising From Soliton and Small Polaron States , 2010 .

[78]  Qiang Zhang,et al.  [In vitro and in vivo study of two kinds of long-circulating solid lipid nanoparticles containing paclitaxel]. , 2002, Yao xue xue bao = Acta pharmaceutica Sinica.

[79]  C. Rice-Evans,et al.  Structure-antioxidant activity relationships of flavonoids and phenolic acids. , 1996, Free radical biology & medicine.

[80]  L. Barth,et al.  Mittheilungen aus dem chemischen Laboratorium in Innsbruck I)Ueber einige Harze [Zersetzungsproducte derselben durch schmelzendes Kali] , 1866 .